Saturday, May 18, 2013 Last update: 4:04 AM
Company Tech News as it Breaks
Trade Events
Tokai Pharmaceuticals, Inc.
News articles for Tokai Pharmaceuticals, Inc.:
Monday, March 4, 2013
- Tokai Pharmaceuticals to Present Data on Galeterone in Advanced Prostate Cancer at 2013 International Congress on Targeted Anticancer Therapies (TAT)Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that clinical data from the ARMOR1 ... read more
Wednesday, February 20, 2013
- Tokai Pharmaceuticals to Participate in Upcoming Investment ConferencesTokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that Martin D. Williams, president and ... read more
Friday, February 15, 2013
- Tokai Pharmaceuticals to Present New Galeterone Mechanism of Action Data at 2013 ASCO GUTokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that new preclinical data demonstrating the differentiated potent and selective ... read more
Thursday, December 13, 2012
- Tokai Pharmaceuticals Doses First Patient in a Phase 2 Study of Galeterone in Advanced Prostate CancerTokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the treatment of the first patient ... read more